← Open Payments lookup

REGAN DEMSHAR: Open Payments

NPI 1972872059 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$473 in 20 payments from 14 companies in 2025. Trend: 2023 $139 · 2024 $422 · 2025 $473

Food & beverage: $473
CompanyPaymentsAmount
Janssen Biotech, Inc.2$139
Daiichi Sankyo Inc.4$83
Genentech USA, Inc.2$39
Rigel Pharmaceuticals, Inc.2$33
Genmab U.S., Inc.1$27
ADC THERAPEUTICS AMERICA, INC.1$24
PFIZER INC.1$20
Sumitomo Pharma America, Inc.1$18
Deciphera Pharmaceuticals Inc.1$17
Incyte Corporation1$16

Products named: RYBREVANT, Enhertu, Tecentriq, DATROWAY, TAVALISSE, Tivdak, ZYNLONTA, PADCEV.

Industry payments across OH — which companies pay providers there.